Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mairead McGinn

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Journal of Medical Genetics. Part A|September 2, 2003
Deafness associated with bilateral facial diplegia, ptosis and hypermobile joints--A new autosomal recessive condition?William Reardon, Mairead McGinn, Mary D King, et al.
Archives of Disease in Childhood. Education and Practice Edition|December 10, 2024
Skeletal abnormalities and a low alkaline phosphataseCatriona Maeve McKay, Noina Abid, Mairead McGinn, et al.
The Lancet. Diabetes & Endocrinology|December 19, 2018
Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trialMichael P Whyte, Jill H Simmons, Scott Moseley, et al.
The New England Journal of Medicine|March 9, 2012
Enzyme-replacement therapy in life-threatening hypophosphatasiaMichael P Whyte, Cheryl R Greenberg, Nada J Salman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Journal of Medical Genetics. Part A|September 2, 2003
Deafness associated with bilateral facial diplegia, ptosis and hypermobile joints--A new autosomal recessive condition?William Reardon, Mairead McGinn, Mary D King, et al.
Archives of Disease in Childhood. Education and Practice Edition|December 10, 2024
Skeletal abnormalities and a low alkaline phosphataseCatriona Maeve McKay, Noina Abid, Mairead McGinn, et al.
The Lancet. Diabetes & Endocrinology|December 19, 2018
Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trialMichael P Whyte, Jill H Simmons, Scott Moseley, et al.
The New England Journal of Medicine|March 9, 2012
Enzyme-replacement therapy in life-threatening hypophosphatasiaMichael P Whyte, Cheryl R Greenberg, Nada J Salman, et al.
Pageof 1